Onconova Therapeutics
ONTX
$1.00
Share price
-0.47%
Change (1 day)
44.25%
Change (1 year)
Categories
Onconova Therapeutics (ONTX) - P/B ratio
P/B ratio as of April 2024 : 1.44
According to Onconova Therapeutics's latest financial reports the company has a price-to-book ratio of 1.44.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Onconova Therapeutics - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.08 | 126.01% |
| 2022-12-31 | 0.4773 | -58.68% |
| 2021-12-31 | 1.16 | -91.72% |
| 2020-12-31 | 14.0 | 279.25% |
| 2019-12-31 | 3.68 | 65.52% |
| 2018-12-31 | 2.22 | -249.4% |
| 2017-12-31 | -1.49 | -149.7% |
| 2016-12-31 | 2.99 | 33.16% |
| 2015-12-31 | 2.25 | -25.64% |
| 2014-12-31 | 3.02 | -0.77% |
| 2013-12-31 | 3.05 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | 2.41 | 67.25% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | 7.89 | 447.68% | 🇺🇸 USA |
 CTI BioPharma
CTIC | -47.3 | -3,384.36% | 🇺🇸 USA |
 Array Technologies ARRY | 3.02 | 109.52% | 🇺🇸 USA |